Skip to navigationSkip to contentSkip to footer
Need Help?770-729-2992
MY ACCOUNT
CART
RayBiotech
RayBiotech
  • Products
    • Multiplex Assays
    • ELISA Kits
    • Proteins
    • Antibodies
    • Flow Cytometry
    • Assay Kits
    • Molecular Biology
    • Other Products
    • Human Cytokine Array C5
    • Human IL-6 ELISA
    • Human Inflammation Array Q3
    • Mouse Cytokine Array C3
    • Recombinant SARS-CoV-2 Spike Protein, S1 Subunit
    • Human Phosphorylation Pathway Profiling Array C55
    • Antibody Arrays
    • Proteome Profiling Arrays
    • Cytometric Bead Arrays
    • Epitope Mapping Peptide Arrays
    • Protein Arrays
    • PTM Multiplex Assays
    • NexaTag® Ultrasensitive Multiplex ELISA
    • Sandwich ELISA
    • Competitive ELISA
    • PTM ELISA
    • NexaTag® Ultrasensitive qIPCR ELISA
    • Indirect ELISA
    • Bridging ELISA
    • Cell-Based ELISA
    • Recombinant Proteins
    • GMP Proteins
    • Native Proteins
    • Peptides
    • Primary Antibodies
    • Secondary Antibodies
    • Flow Cytometry Antibodies
    • Isotype Controls
    • Antibody Pairs
    • Flow Cytometry Antibodies
    • Flow Cytometry Reagents
    • Flow Cytometry Assays
    • Cytometric Bead Arrays
    • Fluorescent Beads
    • Quantum Dots
    • Metabolism Assays
    • Ligand Binding Assays
    • Drug Antibody (DA) & ADA Assays
    • Transcription Factor Activity Assays
    • PCR Assays
    • Nucleic Acid Assays
    • Epigenetics
    • Mitochondrial Assays
    • Reagents
    • Cell Culture
    • Biospecimen Samples
    • Sample Collection & Preparation
    • Lysates
    • Mass Spectometry Reagents
    • Magnetic Beads
    • Lab Equipment and Supplies
    • Biological Buffers

    Featured Products

    Human Cytokine Array C5Human IL-6 ELISAHuman Inflammation Array Q3Mouse Cytokine Array C3Recombinant SARS-CoV-2 Spike Protein, S1 SubunitHuman Phosphorylation Pathway Profiling Array C55
  • Services
    • Multiplex Assay Services
    • ELISA Services
    • Protein Services
    • Antibody Services
    • CRO Services
    • Flow Cytometry Services
    • SIMOA – Single Molecule Array
    • Other Services
    • Quantitative Proteomics Services
    • Discovery Proteomics Services
    • Custom Arrays
    • Array Scanning and Analysis
    • Custom Protein Production
    • GMP Protein Production
    • IHC Controls
    • Stable Cell Line Development
    • Molecular Biology Services
    • Antibody Production
    • Recombinant Antibody Expression
    • Bulk Antibody Production
    • Antibody Conjugation Services
    • Cell Biology Services
    • Epitope Mapping Services
    • Biomarker Discovery
    • Cell Biology Services
    • Antibody Drug Development & Characterization
    • Pharmacokinetic and Pharmacodynamic Analysis
    • Assay Development Services
    • Molecular Biology Services
    • Multiomics Services
    • Diagnostic Assay Development
    • GMP Protein Production
    • Biostatistics and Bioinformatics
    • Bulk Antibody Production
    • QC Testing Services
    • Auto-Western Blot Service
    • COVID-19 Pseudovirus Service
    • Biospecimen Samples & Sample Services
    • RNA & DNA Methylation Detection Services
  • Research Areas
    • Cell Signaling Pathways
    • Areas of Interest
    • Akt Signaling Pathway
    • AMPK Signaling pathway
    • ErbB Signaling Pathway
    • Hedgehog Signaling Pathway
    • HIF1-alpha Signaling Pathway
    • IGFR1 Signaling Pathway
    • JAK-STAT Signaling Pathway
    • MAPK Signaling Pathway
    • mTOR Signaling Pathway
    • NF-kappaB Signaling Pathway
    • Notch Signaling Pathway
    • p53 Signaling Pathway
    • PKC Pathway
    • TGF-beta Signaling Pathway
    • Wnt/beta-Catenin Pathway
    • Antibody Drug Development
    • Autoimmunity & Inflammation
    • Cancer
    • Cardiovascular Disease
    • Infectious Disease & Vaccines
    • Neuroscience
    • Obesity
    • Post Translational Modifications
    • RNA & DNA Modifications
  • Resources
    • Assay Picker Tool
    • Sample Shipment Instructions
    • Sample Preparation Tips
    • Publications / Citations
    • Promotions
    • Resource Library
    • Learning Center
    • Manual Protocols
    • Array Analysis Tools
  • Contact Us
    • Distributors & Service Providers
  • About Us
    • Quality Systems
    • Business Partnerships
    • Careers
    • News & Events
Products
  • Multiplex Assays
  • ELISA Kits
  • Proteins and Peptides
  • Antibodies
  • Flow Cytometry
  • Assay Kits
  • Molecular Biology

Sign up to get promotions on your favorite research tools and research updates.

Sign up to Newsletter (opens in new tab)
Services
  • Multiplex Assay Services
  • ELISA Services
  • Antibody Services
  • Custom Protein Services
  • CRO Services
  • Flow Cytometry Services
  • Simoa – Single Molecule Array Services
Resources
  • Manual Protocols
  • Resource Library
  • Learning Center
  • Array Analysis Tools
  • Publications / Citations
  • Publications by RayBiotech Scientists
About Us
  • About RayBiotech
  • Careers
  • Quality Systems
  • Business Partnerships
  • News & Events
  • Reducing Our Emissions
Contact Us
  • Contacts
  • Distributors
  • Certified Service Providers
ISO 13485:2016cGMP
ISO 17025:2017CLIA
©2007-2026 RayBiotech, Inc. All rights reserved.Life Science Web Design By Supreme
  • Privacy Policy
  • Terms & Conditions
  • ISO Certification
  • Risk Free Guarantee
  • Promotions

Your cart is empty.

  • Home
  • Learning Center
  • Biostatistics & Bioinformatics
  • PCA Analysis
November 21, 2018|Biostatistics & Bioinformatics|Valerie Jones, PhD

PCA Analysis

What is it? Principle Component Analysis (PCA) transforms high-dimensional data into a lower-dimensional structure to improve data presentation, pattern recognition, and analysis. PCA determines which dimensions will result in the largest variability of measurements (e.g., expression of specific proteins) across all samples. It does not separate the different groups from each other as the method is unsupervised.

When is it used? This analysis is used when 1) there are a lot of variables to consider (e.g., expression of thousands of proteins), and 2) you want to ensure that the transformed measurements are independent of each other. PCA can help discover relationships between biomarkers that may not be intuitive.

How does it work?

PCA Analysis: Example

We analyze the protein profile of 1,000 proteins of 4 healthy patients and 4 cancer patients using an antibody-based microarray. This represents high-dimensional data since each sample is characterized by 1,000 variables (or biomarkers). Put another way, the sample point is located in a 1,000 dimension space. We want to find the biomarkers that are the most variable across the samples. We hope that, by doing so, we will be able to identify patterns (i.e., biomarkers that are expressed differently in healthy and diseased patients).

  1. Center & scale data by subtracting the mean of each patient dataset from itself and dividing each patient dataset with its standard deviation, respectively. Now all datasets have a mean of 0 and a standard deviation of 1.
  2. Create Principal Components (i.e., "Data Reduction").
    1. Determine # of Principal Components (PCs). The number of PCs is determined by the minimum number of samples or variables. In this case, the number of patients is lower than the number of proteins analyzed, so 8 PCs are made.
    2. Create PCs. Here, each sample has 8 PCs, where each PC value is a weighted summation of the 1,000 variables.

1 Feedback on "PCA Analysis"

  1. Cat

    September 30 2020 at 6:23 am
    This is very helpful! Thank you for the explanation with great examples!

Leave a Reply

  • Weigh variables differently. Variables that have the largest variance across patient groups are weighted more than variables with smaller variances. Since the variables are weighted differently for each PC, the PCs are uncorrelated to each other. Now the sample point is placed in an 8-dimensional space. The PCs are ordered based on sample variability, such that the first PC (PC1) has the highest variability, PC2 has the second highest variability, and so on.
  • Reduce data dimension. We plot the PCs against each other, and we can now use these plots to create new axes via data transformation (Figure 1). Thus, we reduce the space from 1,000 dimensions to 8 dimensions.
  • Compare PCs visually using a scatter plot to observe patterns (Figure 2). PC1 and PC2 are usually the PCs that are plotted against each other because they result in the highest and second highest distribution variances, respectively, of all PCs. Groups that are more similar to each other will have higher overlap on the PCA plot. Therefore, group similarity or dissimilarity can be easily and visually discerned using a PCA plot.
  • PCA analysis. Biomarkers making greater contributions to the PCs can be identified as they will have higher weights.
  • PCA Figure 1 — Centering and transforming PC data

    Figure 1. An example of centering and transforming PC data. A) Scatter plot of one PC versus another. B) Data is centered. C) Axes are transformed to align with the directions of maximum variance.

    PCA Figure 2 — PCA plot of biomarkers

    Figure 2. PCA plot of 1,000 biomarkers among 4 healthy (blue) and diseased (pink) patients. The weighted PCs separate the two groups visually along PC1 and PC2.

    What does the data look like? PCA analyses are represented as 1) a figure (like Figure 2) or 2) a table listing the first few PCs. Biomarkers that were weighted the most can be considered as potential biomarkers for follow-up validation studies. Since biology is complicated and we still have a lot to learn, PCA analysis may not identify variables that are intuitive.